< previous page page_416 next page >

Page 416
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
89. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 150.
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
90. G. Pratesi et al., "Differential Efficacy of Flavone Acetic Acid Against Liver Versus Lung Metastases in a Human Tumor Xenograft," British Journal of Cancer 63 (1): 71-74 (1991).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
91. M.C. Bibby et al., "Anti-rumor Activity of Flavone Acetic Acid (NSC 347512) in MiceInfluence of Immune Status," British Journal of Cancer 63 (1): 5742 (1991).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
92. D.J. Kerr et al., "Phase I and Pharmacokinetic Study of Flavone Acetic Acid," Cancer Research 47 (24 Pt 1): 6776-81 (1987).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
93. R.L. Hornung et al., "Augmentation of Natural Killer Activity, Induction of IFN and Development of Tumor Immunity During the Successful Treatment of Established Murine Renal Cancer Using Flavone Acetic Acid and IL-2," Journal of Immunology 141 (10): 3671-79 (1988).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
94. R.H. Wiltrout et al., "Flavone-8-acetic Acid Augments Systemic Natural Killer Cell Activity and Synergizes with IL-2 for Treatment of Murine Renal Cancer," Journal of Immunology 140 (9): 3261-45 (1988).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
95. G. Pratesi et al., "Role of T Cells and Tumor Necrosis Factor in Antitumor Activity and Toxicity of Flavone Acetic Acid," European Journal of Cancer 26 (10): 1079-83 (1990).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
96. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 152-54.
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
97. J. Masquelier, OPCs in Practice (Rome, Italy: Alpha Omega Editrice, 1995), 118-20.
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
98. J.P. Boissin et al., "Chorioretinal Circulation and Dazzling Use of Procyanidol Oligomers," Bulletin Société d'Opthalmologie Fr 88 (173-74): 177-79 (1988).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
99. L.M. Larocca et al., "Growth-inhibitory Effect of Quercetin and Presence of Type II Estrogen Binding Sites in Primary Human Transitional Cell Carcinomas," Journal of Urology 152 (3): 1029-33 (1994).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
100. F.O. Ranelletti et al., "Growth-Inhibitory Effect of Quercetin and Presence of Type II Estrogen Binding Sites in Human Colon Cancer Cell Lines and Primary Colorectal Tumors," International Journal of Cancer 50 (3): 486-92 (1992).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
101. M. Yoshida et al., "The Effect of Quercetin on Cell Cycle Progression and Growth of Human Gastric Cancer Cells," FEBS Letters 260 (1): 10-13 (1990).

 
< previous page page_416 next page >

If you like this book, buy it!